{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T10:10:35Z","timestamp":1778494235454,"version":"3.51.4"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015063","name":"National Institute of Technology Calicut","doi-asserted-by":"publisher","award":["-2022"],"award-info":[{"award-number":["-2022"]}],"id":[{"id":"10.13039\/501100015063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015063","name":"National Institute of Technology Calicut","doi-asserted-by":"publisher","award":["FRG\/2022\/SoBT_03"],"award-info":[{"award-number":["FRG\/2022\/SoBT_03"]}],"id":[{"id":"10.13039\/501100015063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["09\/0874(13665)\/2022-EMR-I"],"award-info":[{"award-number":["09\/0874(13665)\/2022-EMR-I"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.compbiomed.2025.109693","type":"journal-article","created":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T08:54:20Z","timestamp":1737795260000},"page":"109693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The developmental and inflammatory disease target protein ADAM17 is vulnerable to off-target interaction by the drug eltrombopag: Insights from molecular modeling"],"prefix":"10.1016","volume":"186","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0709-6688","authenticated-orcid":false,"given":"Shahid","family":"Puthiyottil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2373-3015","authenticated-orcid":false,"given":"Deepthi","family":"Jose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2691-9854","authenticated-orcid":false,"given":"Nishamol","family":"Kuriakose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6822-9325","authenticated-orcid":false,"given":"Tom","family":"Skaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiomed.2025.109693_bib1","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.282.5392.1281","article-title":"An essential role for ectodomain shedding in mammalian development","volume":"282","author":"Peschon","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.compbiomed.2025.109693_bib2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1167\/iovs.12-11130","article-title":"ADAM17 transactivates EGFR signaling during embryonic eyelid closure","volume":"54","author":"Hassemer","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.compbiomed.2025.109693_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/febs.16923","article-title":"The protease ADAM17 at the crossroads of disease: revisiting its significance in inflammation, cancer, and beyond,","volume":"291","author":"Saad","year":"2024","journal-title":"FEBS J."},{"key":"10.1016\/j.compbiomed.2025.109693_bib4","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201900430","article-title":"Mutagenesis of the ADAM17-phosphatidylserine\u2013binding motif leads to embryonic lethality in mice","volume":"2","author":"Veit","year":"2019","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.compbiomed.2025.109693_bib5","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3390\/molecules26040944","article-title":"Strategies to target ADAM17 in disease: from its discovery to the iRhom revolution","volume":"26","author":"Calligaris","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.compbiomed.2025.109693_bib6","first-page":"103575","article-title":"Small-molecule modulators of tumor necrosis factor signaling, Drug Discov","volume":"28","author":"Ch\u00e9dotal","year":"2023","journal-title":"Today Off."},{"key":"10.1016\/j.compbiomed.2025.109693_bib7","first-page":"3408","article-title":"Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme, Proc. Natl. Acad. Sci. U","volume":"95","author":"Maskos","year":"1998","journal-title":"S. A"},{"key":"10.1016\/j.compbiomed.2025.109693_bib8","first-page":"4931","article-title":"Key feature of the catalytic cycle of TNF-\u03b1 converting enzyme involves communication between distal protein sites and the enzyme catalytic core, Proc. Natl. Acad. Sci. U","volume":"104","author":"Solomon","year":"2007","journal-title":"S. A"},{"key":"10.1016\/j.compbiomed.2025.109693_bib9","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cardiores.2005.12.002","article-title":"Structure and function of matrix metalloproteinases and TIMPs","volume":"69","author":"Nagase","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.compbiomed.2025.109693_bib10","doi-asserted-by":"crossref","first-page":"16859","DOI":"10.18632\/aging.203200","article-title":"Molecular switch in human diseases-disintegrin and metalloproteinases, ADAM17","volume":"13","author":"Yang","year":"2021","journal-title":"Aging"},{"key":"10.1016\/j.compbiomed.2025.109693_bib11","doi-asserted-by":"crossref","first-page":"1067134","DOI":"10.1155\/2018\/1067134","article-title":"The EGFR-ADAM17 Axis in chronic obstructive pulmonary disease and cystic fibrosis lung pathology","volume":"2018","author":"Stolarczyk","year":"2018","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.compbiomed.2025.109693_bib12","article-title":"ADAM17, A key player of cardiac inflammation and fibrosis in heart failure development during chronic catecholamine stress, front","volume":"9","author":"Adu-Amankwaah","year":"2021","journal-title":"Cell Dev. Biol."},{"key":"10.1016\/j.compbiomed.2025.109693_bib13","doi-asserted-by":"crossref","first-page":"1059376","DOI":"10.3389\/fimmu.2022.1059376","article-title":"Immunomodulatory role of metalloproteinase ADAM17 in tumor development","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.compbiomed.2025.109693_bib14","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1021\/jm0491703","article-title":"A comparison of the binding sites of matrix metalloproteinases and tumor necrosis factor-\u03b1 converting Enzyme: implications for selectivity,","volume":"48","author":"Lukacova","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiomed.2025.109693_bib15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bmcl.2008.11.034","article-title":"Discovery of novel spirocyclopropyl hydroxamate and carboxylate compounds as TACE inhibitors","volume":"19","author":"Guo","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.compbiomed.2025.109693_bib16","article-title":"Novel structured ADAM17 small-molecule inhibitor represses ADAM17\/Notch pathway activation and the NSCLC cells' resistance to anti-tumour drugs, Front","volume":"14","author":"Chi","year":"2023","journal-title":"Pharmacol"},{"key":"10.1016\/j.compbiomed.2025.109693_bib17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1747-0285.2010.00950.x","article-title":"Tumor necrosis factor alpha converting enzyme: an encouraging target for various inflammatory disorders","volume":"75","author":"Bahia","year":"2010","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.compbiomed.2025.109693_bib18","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.bmcl.2010.01.148","article-title":"Discovery and SAR of hydantoin TACE inhibitors","volume":"20","author":"Yu","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.compbiomed.2025.109693_bib19","first-page":"424","article-title":"Preclinical activity of eltrombopag (SB-497115), an oral","volume":"vol. 27","author":"Erickson-Miller","year":"2009"},{"issue":"Suppl 1","key":"10.1016\/j.compbiomed.2025.109693_bib20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00277-010-0953-x","article-title":"Eltrombopag: an update on the novel, non-peptide thrombopoietin receptor agonist for the treatment of immune thrombocytopenia","volume":"89","author":"K\u00fchne","year":"2010","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.compbiomed.2025.109693_bib21","first-page":"11","article-title":"Eltrombopag and improved hematopoiesis in refractory aplastic anemia, N. Engl","volume":"367","author":"Olnes","year":"2012","journal-title":"J. Med."},{"key":"10.1016\/j.compbiomed.2025.109693_bib22","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1182\/blood-2013-10-534743","article-title":"Eltrombopag restores trilineage hematopoiesis in refractory severe aplastic anemia that can be sustained on discontinuation of drug","volume":"123","author":"Desmond","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.compbiomed.2025.109693_bib23","doi-asserted-by":"crossref","DOI":"10.1182\/hem.V19.3.2022312","article-title":"Eltrombopag in frontline therapy for severe aplastic anemia: a race against time,","volume":"19","author":"Anderson","year":"2022","journal-title":"Hematologist"},{"key":"10.1016\/j.compbiomed.2025.109693_bib24","first-page":"11","volume":"386","author":"Peffault de Latour","year":"2022","journal-title":"J. Med."},{"key":"10.1016\/j.compbiomed.2025.109693_bib25","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1016\/S2352-3026(23)00395-2","article-title":"Activity and safety of eltrombopag in combination with cyclosporin A as first-line treatment of adults with severe aplastic anaemia (SOAR): a phase 2, single-arm study","volume":"11","author":"Scheinberg","year":"2024","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.compbiomed.2025.109693_bib26","author":"Promacta (eltrombopag)"},{"key":"10.1016\/j.compbiomed.2025.109693_bib27","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1103\/PhysRevB.37.785","article-title":"Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density","volume":"37","author":"Lee","year":"1988","journal-title":"Phys. Rev. B"},{"key":"10.1016\/j.compbiomed.2025.109693_bib28","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/ct100651f","article-title":"Parameterization of a B3LYP specific correction for noncovalent interactions and basis set superposition error on a gigantic data set of CCSD(T) quality noncovalent interaction energies","volume":"7","author":"Schneebeli","year":"2011","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.compbiomed.2025.109693_bib29","author":"Frisch","year":"2016","journal-title":"Gaussian\u02dc16 Revision A.03"},{"key":"10.1016\/j.compbiomed.2025.109693_bib30","first-page":"1","article-title":"Biomolecular interactions between the antibacterial ceftolozane and the human inflammatory disease target ADAM17: a drug repurposing study","author":"Sunil","year":"2023","journal-title":"J. Biomol. Struct. Dyn"},{"key":"10.1016\/j.compbiomed.2025.109693_bib31","unstructured":"AcePrep: ligand protonation and preparation, (n.d.). https:\/\/playmolecule.com\/aceprep\/(accessed February 21, 2024)."},{"key":"10.1016\/j.compbiomed.2025.109693_bib32","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiomed.2025.109693_bib33","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/bioinformatics\/btl150","article-title":"Molecular complexes at a glance: automated generation of two-dimensional complex diagrams","volume":"22","author":"Stierand","year":"2006","journal-title":"Bioinformatics"},{"key":"10.1016\/j.compbiomed.2025.109693_bib34","doi-asserted-by":"crossref","first-page":"W337","DOI":"10.1093\/nar\/gkx333","article-title":"ProteinsPlus: a web portal for structure analysis of macromolecules","volume":"45","author":"F\u00e4hrrolfes","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2025.109693_bib35","doi-asserted-by":"crossref","first-page":"W48","DOI":"10.1093\/nar\/gkaa235","article-title":"ProteinsPlus: interactive analysis of protein\u2013ligand binding interfaces","volume":"48","author":"Sch\u00f6ning-Stierand","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2025.109693_bib36","doi-asserted-by":"crossref","first-page":"W368","DOI":"10.1093\/nar\/gki464","article-title":"H++: a server for estimating pKas and adding missing hydrogens to macromolecules","volume":"33","author":"Gordon","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2025.109693_bib37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.compbiomed.2025.109693_bib38","series-title":"Struct. Genomics","first-page":"257","article-title":"Parameterization of a dioxygen binding metal site using the MCPB.py program","author":"Li","year":"2021"},{"key":"10.1016\/j.compbiomed.2025.109693_bib39","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/jcc.540110404","article-title":"Atomic charges derived from semiempirical methods","volume":"11","author":"Besler","year":"1990","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiomed.2025.109693_bib40","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/(SICI)1097-461X(1996)60:7<1271::AID-QUA8>3.0.CO;2-W","article-title":"Calculation of intramolecular force fields from second-derivative tensors","volume":"60","author":"Seminario","year":"1996","journal-title":"Int. J. Quant. Chem."},{"key":"10.1016\/j.compbiomed.2025.109693_bib41","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1021\/j100142a004","article-title":"A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model,","volume":"97","author":"Bayly","year":"1993","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.compbiomed.2025.109693_bib42","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","article-title":"ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB","volume":"11","author":"Maier","year":"2015","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.compbiomed.2025.109693_bib43","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.compbiomed.2025.109693_bib44","doi-asserted-by":"crossref","first-page":"164122","DOI":"10.1063\/1.4799236","article-title":"Efficiently finding the minimum free energy path from steepest descent path","volume":"138","author":"Chen","year":"2013","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.compbiomed.2025.109693_bib45","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"Chimera\u2013a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiomed.2025.109693_bib46","doi-asserted-by":"crossref","first-page":"W530","DOI":"10.1093\/nar\/gkab294","article-title":"2021: expanding the scope of the protein-ligand interaction profiler to DNA and RNA","volume":"49","author":"Adasme","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2025.109693_bib47","first-page":"3759","article-title":"MODE-TASK: large-scale protein motion tools, Bioinforma. Oxf","volume":"34","author":"Ross","year":"2018","journal-title":"Englera"},{"key":"10.1016\/j.compbiomed.2025.109693_bib48","doi-asserted-by":"crossref","first-page":"6281","DOI":"10.1021\/acs.jctc.1c00645","article-title":"gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS,","volume":"17","author":"Vald\u00e9s-Tresanco","year":"2021","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.compbiomed.2025.109693_bib49","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"T.D.Jr. Mcgee, J.M. Swails, N. Homeyer, H. Gohlke, A.E. Roitberg, MMPBSA.py: an efficient program for end-state free energy calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.compbiomed.2025.109693_bib50","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/jcc.10379","article-title":"Converging free energy estimates: MM-PB(GB)SA studies on the protein-protein complex Ras-Raf","volume":"25","author":"Gohlke","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiomed.2025.109693_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208102","article-title":"Iron chelating properties of Eltrombopag: investigating its role in thalassemia-induced osteoporosis","volume":"13","author":"Punzo","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.compbiomed.2025.109693_bib52","doi-asserted-by":"crossref","first-page":"E237","DOI":"10.1002\/ajh.25550","article-title":"Iron mobilization in a real life cohort of aplastic anemia patients treated with eltrombopag","volume":"94","author":"Fattizzo","year":"2019","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.compbiomed.2025.109693_bib53","article-title":"Novel perspectives on thrombopoietin receptor agonists applications","author":"Stafylidis","year":"2024","journal-title":"H\u00e4mostaseologie"},{"key":"10.1016\/j.compbiomed.2025.109693_bib54","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.3390\/molecules24234373","article-title":"A repurposing approach for uncovering the anti-tubercular activity of FDA-approved drugs with potential multi-targeting profiles","volume":"24","author":"Battah","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.compbiomed.2025.109693_bib55","doi-asserted-by":"crossref","first-page":"130009","DOI":"10.1016\/j.bmcl.2024.130009","article-title":"Novel drug discovery approaches for MMP-13 inhibitors in the treatment of osteoarthritis","volume":"114","author":"Wang","year":"2024","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.compbiomed.2025.109693_bib56","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1073\/pnas.1505649112","article-title":"iRhoms 1 and 2 are essential upstream regulators of ADAM17-dependent EGFR signaling","volume":"112","author":"Li","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.compbiomed.2025.109693_bib57","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1021\/acs.jproteome.5b00691","article-title":"Skin barrier defects caused by keratinocyte-specific deletion of ADAM17 or EGFR are based on highly similar proteome and degradome alterations","volume":"15","author":"Tholen","year":"2016","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.compbiomed.2025.109693_bib58","doi-asserted-by":"crossref","first-page":"39780","DOI":"10.1038\/srep39780","article-title":"ADAM17\/EGFR axis promotes transglutaminase-dependent skin barrier formation through phospholipase C \u03b31 and protein kinase C pathways","volume":"6","author":"Wolf","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2025.109693_bib59","first-page":"119141","article-title":"ADAM17 orchestrates Interleukin-6, TNF\u03b1 and EGF-R signaling in inflammation and cancer, Biochim. Biophys","volume":"1869","author":"Schumacher","year":"2022","journal-title":"Acta BBA - Mol. Cell Res"},{"key":"10.1016\/j.compbiomed.2025.109693_bib60","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1139\/o06-179","article-title":"Substitution of methionine 435 with leucine, isoleucine, and serine in tumor necrosis factor alpha converting enzyme inactivates ectodomain shedding activity","volume":"85","author":"P\u00e9rez","year":"2007","journal-title":"Biochem. Cell. Biol."},{"key":"10.1016\/j.compbiomed.2025.109693_bib61","doi-asserted-by":"crossref","first-page":"463","DOI":"10.3390\/biomedicines8110463","article-title":"Functional characterization of colon-cancer-associated variants in ADAM17 affecting the catalytic domain","volume":"8","author":"Dobert","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.compbiomed.2025.109693_bib62","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41380-018-0091-8","article-title":"A rare loss-of-function variant of ADAM17 is associated with late-onset familial Alzheimer disease,","volume":"25","author":"Hartl","year":"2020","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.compbiomed.2025.109693_bib63","doi-asserted-by":"crossref","first-page":"9552","DOI":"10.1038\/s41598-021-89063-0","article-title":"Functionally confirmed compound heterozygous ADAM17 missense loss-of-function variants cause neonatal inflammatory skin and bowel disease 1","volume":"11","author":"Imoto","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2025.109693_bib64","first-page":"331","article-title":"The effect of polymorphisms and other biomarkers on infliximab exposure in paediatric inflammatory bowel disease: development of a population pharmacokinetic model, pediatr","volume":"26","author":"Clemente-Bautista","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.compbiomed.2025.109693_bib65","doi-asserted-by":"crossref","first-page":"114225","DOI":"10.1016\/j.biopha.2023.114225","article-title":"Single nucleotide polymorphisms in ADAM17, IL23R and SLCO1C1 genes protect against infliximab failure in adults with Crohn's disease, Biomed. Pharmacother","volume":"159","author":"Laserna-Mendieta","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.compbiomed.2025.109693_bib66","first-page":"1088","article-title":"Apoptosis and inflammatory genes variants in primary non-response to anti-TNF therapy in Crohn's disease patients, Eur","volume":"35","author":"Lykowska-Szuber","year":"2023","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.compbiomed.2025.109693_bib67","first-page":"81","article-title":"ADAM17 genetic variants and the response of TNF-\u03b1 inhibitor in rheumatoid arthritis patients, pharmacogenomics pers","volume":"13","author":"Kim","year":"2020","journal-title":"M\u00e9d."},{"key":"10.1016\/j.compbiomed.2025.109693_bib68","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1086\/315214","article-title":"Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options","volume":"181","author":"Gogos","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.compbiomed.2025.109693_bib69","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.3390\/ijms22052719","article-title":"The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics","volume":"22","author":"Jang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.compbiomed.2025.109693_bib70","doi-asserted-by":"crossref","first-page":"84","DOI":"10.18053\/jctres.02.201603.005","article-title":"The role of TNF-\u03b1 in rheumatoid arthritis: a focus on regulatory T cells,","volume":"2","author":"Farrugia","year":"2016","journal-title":"J. Clin. Transl. Res."},{"key":"10.1016\/j.compbiomed.2025.109693_bib71","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/art.41275","article-title":"Fenebrutinib versus placebo or adalimumab in rheumatoid arthritis: a randomized, double-blind, phase II trial,","volume":"72","author":"Cohen","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.compbiomed.2025.109693_bib72","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/1744666X.2020.1858803","article-title":"Efficacy and safety of subcutaneous infliximab versus adalimumab, etanercept and intravenous infliximab in patients with rheumatoid arthritis: a systematic literature review and meta-analysis","volume":"17","author":"Caporali","year":"2021","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.compbiomed.2025.109693_bib73","first-page":"659","article-title":"Response to treatment with intravenous golimumab or infliximab in rheumatoid arthritis patients: PROMIS results from the real-world observational phase 4 AWARE study, rheumatol","volume":"10","author":"Bingham","year":"2023","journal-title":"Ther"},{"key":"10.1016\/j.compbiomed.2025.109693_bib74","article-title":"Efficacy, safety and immunogenicity of etanercept biosimilars versus reference biologics in patients with rheumatoid arthritis: a meta-analysis, Front","volume":"14","author":"Hu","year":"2023","journal-title":"Pharmacol"},{"key":"10.1016\/j.compbiomed.2025.109693_bib75","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/ncprheum0797","article-title":"Drug insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis","volume":"4","author":"Moss","year":"2008","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"10.1016\/j.compbiomed.2025.109693_bib76","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.3390\/jcm12051986","article-title":"Recent advances in small molecule inhibitors for the treatment of osteoarthritis","volume":"12","author":"Lin","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.compbiomed.2025.109693_bib77","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1021\/jo400406g","article-title":"Computational exploration of zinc binding groups for HDAC inhibition","volume":"78","author":"Chen","year":"2013","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.compbiomed.2025.109693_bib78","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jphs.2023.11.005","article-title":"An ADAM17 selective inhibitor promotes glucose uptake by activating AMPK","volume":"154","author":"Toma","year":"2024","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.compbiomed.2025.109693_bib79","first-page":"779","article-title":"Recent developments and strategies for the discovery of TACE inhibitors, Expert Opin","volume":"15","author":"Murumkar","year":"2020","journal-title":"Drug Discov"},{"key":"10.1016\/j.compbiomed.2025.109693_bib80","doi-asserted-by":"crossref","first-page":"779119","DOI":"10.3389\/fimmu.2021.779119","article-title":"ADAM metalloproteinase domain 17 regulates cholestasis-associated liver injury and sickness behavior development in mice","volume":"12","author":"Almishri","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.compbiomed.2025.109693_bib81","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/ijms22010097","article-title":"Effects of eltrombopag on in vitro macrophage polarization in pediatric immune thrombocytopenia","volume":"22","author":"Di Paola","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.compbiomed.2025.109693_bib82","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3390\/ph15040419","article-title":"Of eltrombopag in aplastic anemia following autologous stem cell transplant: case report and review of the literature","volume":"15","author":"Bortolotti","year":"2022","journal-title":"Pharmaceuticals"}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482525000435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482525000435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:44:03Z","timestamp":1777380243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482525000435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":82,"alternative-id":["S0010482525000435"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.109693","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The developmental and inflammatory disease target protein ADAM17 is vulnerable to off-target interaction by the drug eltrombopag: Insights from molecular modeling","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.109693","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109693"}}